Akari Therapeutics (AKTX)
NASDAQ:AKTX
Holding AKTX?
Track your performance easily

Akari Therapeutics (AKTX) Financial Statements

275 Followers

Akari Therapeutics Financial Overview

Akari Therapeutics's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Akari Therapeutics is scheduled to report earnings on April 8, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 22Jun 22Mar 22
Income Statement-
Total Revenue---$ 0.00$ 0.00
Gross Profit-----
EBIT$ -7.51M$ -5.57M-$ -5.82M$ -5.24M
EBITDA$ -7.51M$ -5.55M-$ -5.82M$ -5.24M
Net Income Common Stockholders$ -7.56M$ -5.57M-$ -5.68M$ -5.18M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 4.20M$ 1.30M$ 13.20M$ 8.15M$ 16.72M
Total Assets$ 5.08M$ 2.77M$ 13.83M$ 11.37M$ 19.45M
Total Debt$ 1.00M$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -3.20M$ -1.30M$ -13.20M$ -8.15M$ -16.72M
Total Liabilities$ 60.97M$ 58.52M$ 12.04M$ 3.05M$ 5.52M
Stockholders Equity$ -3.70M$ -3.55M$ 1.79M$ 8.33M$ 13.93M
Cash Flow-
Free Cash Flow-$ -4.04M-$ -8.57M$ -5.05M
Operating Cash Flow$ -4.89M$ -4.04M-$ -8.57M$ -5.05M
Investing Cash Flow-----
Financing Cash Flow$ 7.76M$ 1.51M-$ 0.00$ 12.37M
Currency in USD

Akari Therapeutics Earnings and Revenue History

Akari Therapeutics Debt to Assets

Akari Therapeutics Cash Flow

Akari Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis